| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-27345SS | |||
| Azide and BSA Free | NBP2-80793 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-90207-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-56502SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-56573SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70709 | |||
![Western Blot: RelA/NFkB p65 [p Ser276] Antibody [NBP1-77807] - TNF Induces phosphorylation of p65 in KBM-5 cells. Cytoplasmic and nuclear protein lysates prepared after 0, 5, 10, 15, 30 and 60 minutes of 0.1 nM TNF treatment of KBM-5 cells shows inducible phosphorylation using phospho specific polyclonal anti-human pS276 p65. Pan reactive anti p65 was used a control to show the presence of total p65 in both the cytoplasmic and nuclear extracts. Phosphorylation of p65 occurs after approximately 10 min of TNF exposure. Migration of phosphorylated p65 into the nucleus occurs within a similar time frame. HRP conjugated Gt-anti-Rabbit IgG was used to develop the blot using a chemi -luminescent detection method.](http://images.novusbio.com/fullsize/RelA-NFkB p65 [p Ser276] Antibody-Western Blot-NBP1-77807-img0010.jpg "Western Blot: RelA/NFkB p65 [p Ser276] Antibody [NBP1-77807] - TNF Induces phosphorylation of p65 in KBM-5 cells. Cytoplasmic and nuclear protein lysates prepared after 0, 5, 10, 15, 30 and 60 minutes of 0.1 nM TNF treatment of KBM-5 cells shows inducible phosphorylation using phospho specific polyclonal anti-human pS276 p65. Pan reactive anti p65 was used a control to show the presence of total p65 in both the cytoplasmic and nuclear extracts. Phosphorylation of p65 occurs after approximately 10 min of TNF exposure. Migration of phosphorylated p65 into the nucleus occurs within a similar time frame. HRP conjugated Gt-anti-Rabbit IgG was used to develop the blot using a chemi -luminescent detection method.")
![Immunohistochemistry: RelA/NFkB p65 [p Ser276] Antibody [NBP1-77807] - Diluted to1:500 to detect p65 in human kidney tissue. Tissue was formalin fixed and paraffin embedded. No pre-treatment of sample was required. The image shows the localization of antibody as the precipitated red signal, with a hematoxylin purple nuclear counter stain.](http://images.novusbio.com/fullsize/RelA-NFkB-p65-[p-Ser276]-Antibody-Immunohistochemistry-NBP1-77807-img0007.jpg)
![Western Blot: RelA/NFkB p65 [p Ser276] Antibody [NBP1-77807] - pS529 shows phospho p65 staining in carcinoma cells.](http://images.novusbio.com/fullsize/RelA-NFkB-p65-[p-Ser276]-Antibody-Western-Blot-NBP1-77807-img0005.jpg)
![Western Blot: RelA/NFkB p65 [p Ser276] Antibody [NBP1-77807] - pS276 shows phospho p65 staining in carcinoma cells. Western blot of total protein lysates from various human head and neck tumors shows phospho p65 staining in tumor cell lines using phospho specific polyclonal anti-human pS276 p65. Lanes 1-6 contain protein lysates from human squamal carcinoma cell lines. Lane 7 is a protein lysate from a primary culture of human keratinocytes and does not show significant levels of phosphorylated p65. Lane 8 contains protein lysate from ATCC SCC9 cells (also a head and neck squamal carcinoma). Lane 9 contains lysate from EGF-induced human derived A431 cells. Lane 10 (not shown) contains a molecular weight standard. Concurrent staining with anti-beta microtubulin (not shown) was used to confirm equal protein loading in all lanes. HRP conjugated Gt-anti-Rabbit IgG was used to develop the blot using a chemiluminescent detection method.](http://images.novusbio.com/fullsize/RelA-NFkB-p65-[p-Ser276]-Antibody-Western-Blot-NBP1-77807-img0006.jpg)
![Western Blot: RelA/NFkB p65 [p Ser276] Antibody [NBP1-77807] - TNF Induces phosphorylation of p65 in KBM-5 cells.](http://images.novusbio.com/fullsize/RelA-NFkB-p65-[p-Ser276]-Antibody-Western-Blot-NBP1-77807-img0008.jpg)
![Western Blot: IRF3 Antibody [NBP1-78769] - Whole cell lysate from mouse bone marrow dendritic (D; 50 and 15 mcg for WB; 1 mg for IP, 20% of IP loaded), and NIH3T3 (M; 50 mcg) cells. Affinity purified rabbit anti-IRF3 antibody used for WB at 0.4 mcg/ml (A) and 1 mcg/ml (B) and used for IP at 6 mcg/mg lysate. IRF3 was also immunoprecipitated by rabbit anti-IRF3 antibody NBP1-78768 which recognizes a disparate epitope.](http://images.novusbio.com/fullsize/IRF3-Antibody-Western-Blot-NBP1-78769-img0002.jpg "<b>Independent Antibodies Validation and Biological Strategies Validation.</b>Western Blot: IRF3 Antibody [NBP1-78769] - Whole cell lysate from mouse bone marrow dendritic (D; 50 and 15 mcg for WB; 1 mg for IP, 20% of IP loaded), and NIH3T3 (M; 50 mcg) cells. Affinity purified rabbit anti-IRF3 antibody used for WB at 0.4 mcg/ml (A) and 1 mcg/ml (B) and used for IP at 6 mcg/mg lysate. IRF3 was also immunoprecipitated by rabbit anti-IRF3 antibody NBP1-78768 which recognizes a disparate epitope.")
![Western Blot: IL-1 beta/IL-1F2 Antibody (43N3D8) [NBP2-27345] - Analysis of Interleukin-1 beta in A) full-length recombinant protein and B) human ThP1 lysate using Interleukin-1 beta antibody at 1 ug/ml and 5 ug/ml, respectively. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/IL-1-beta-IL-1F2-Antibody-43N3D8-Western-Blot-NBP2-27345-img0008.jpg "Western Blot: IL-1 beta/IL-1F2 Antibody (43N3D8) [NBP2-27345] - Analysis of Interleukin-1 beta in A) full-length recombinant protein and B) human ThP1 lysate using Interleukin-1 beta antibody at 1 ug/ml and 5 ug/ml, respectively. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.")
![<b>Biological Strategies Validation. </b>Flow Cytometry: IL-1 beta/IL-1F2 Antibody (43N3D8) [NBP2-27345] - Intracellular staining of Interleukin-1 beta positive T cells (upper panel) & monocytes (lower panel) from stimulated PBMC (with a cocktail of TLR ligands and PMA/IM for 6h) using Interleukin-1 beta antibody at 0.5 ug/10^6 cells.](http://images.novusbio.com/fullsize/IL-1-beta-IL-1F2-Antibody-43N3D8-Flow-Cytometry-NBP2-27345-img0006.jpg)
![Western Blot: IL-1 beta/IL-1F2 Antibody (43N3D8) [NBP2-27345] - Analysis of full length human IL-1 beta recombinant protein (10ng/well) using IL1 beta Antibody (NBP2-27345) at 1:1000 (left lane) and 1:100 (right lane).](http://images.novusbio.com/fullsize/IL-1-beta-IL-1F2-Antibody-43N3D8-Western-Blot-NBP2-27345-img0009.jpg)
![Immunohistochemistry-Paraffin: IL-1 beta/IL-1F2 Antibody (43N3D8) [NBP2-27345] - Analysis of Interleukin-1 beta in human kidney tissue using Interleukin-1 beta antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/IL-1-beta-IL-1F2-Antibody-43N3D8-Immunohistochemistry-Paraffin-NBP2-27345-img0007.jpg)
![SDS-Page: Recombinant Human NLRP3/NALP3 Protein [H00114548-P01] - 12.5% SDS-PAGE stained with Coomassie Blue.](http://images.novusbio.com/fullsize/Recombinant-Human-NLRP3-NALP3-Protein-SDS-Page-H00114548-P01-img0002.jpg "SDS-Page: Recombinant Human NLRP3/NALP3 Protein [H00114548-P01] - 12.5% SDS-PAGE stained with Coomassie Blue.")
![Immunohistochemistry-Paraffin: NLRP3/NALP3 Antibody [NBP1-90207] - Staining of human tonsil shows moderate cytoplasmic positivity in non - germinal center cells.](http://images.novusbio.com/fullsize/NLRP3-NALP3-Antibody-Immunohistochemistry-Paraffin-NBP1-90207-img0011.jpg "Immunohistochemistry-Paraffin: NLRP3/NALP3 Antibody [NBP1-90207] - Staining of human tonsil shows moderate cytoplasmic positivity in non - germinal center cells.")
![Immunohistochemistry-Paraffin: NLRP3/NALP3 Antibody [NBP1-90207] - Staining of human lung shows moderate cytoplasmic positivity in macrophages.](http://images.novusbio.com/fullsize/NLRP3-NALP3-Antibody-Immunohistochemistry-Paraffin-NBP1-90207-img0008.jpg)
![Immunohistochemistry-Paraffin: NLRP3/NALP3 Antibody [NBP1-90207] - Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/NLRP3-NALP3-Antibody-Immunohistochemistry-Paraffin-NBP1-90207-img0009.jpg)
![Immunohistochemistry-Paraffin: NLRP3/NALP3 Antibody [NBP1-90207] - Staining of human spleen shows cytoplasmic positivity in lymphoid cells.](http://images.novusbio.com/fullsize/NLRP3-NALP3-Antibody-Immunohistochemistry-Paraffin-NBP1-90207-img0010.jpg)
![Western Blot: TAK1 Antibody (JM73-19) [NBP2-67180] - Western blot analysis of TAK1 on different lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody (1/500) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:5,000 dilution was used for 1 hour at room temperature. Positive control: Lane 1: MCF-7 cell lysate Lane 2: A431 cell lysate](http://images.novusbio.com/fullsize/TAK1-Antibody-JM73-19-Western-Blot-NBP2-67180-img0008.jpg "Western Blot: TAK1 Antibody (JM73-19) [NBP2-67180] - Western blot analysis of TAK1 on different lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody (1/500) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:5,000 dilution was used for 1 hour at room temperature. Positive control: Lane 1: MCF-7 cell lysate Lane 2: A431 cell lysate")
![Immunocytochemistry/Immunofluorescence: TAK1 Antibody (JM73-19) [NBP2-67180] - Staining TAK1 in N2A cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/TAK1-Antibody-JM73-19-Immunocytochemistry-Immunofluorescence-NBP2-67180-img0007.jpg)
![Immunohistochemistry-Paraffin: TAK1 Antibody (JM73-19) [NBP2-67180] - Analysis of paraffin-embedded mouse stomach tissue using anti-TAK1 antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/TAK1-Antibody-JM73-19-Immunohistochemistry-Paraffin-NBP2-67180-img0005.jpg)
![Flow Cytometry: TAK1 Antibody (JM73-19) [NBP2-67180] - Analysis of A431 cells with TAK1 antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).](http://images.novusbio.com/fullsize/TAK1-Antibody-JM73-19-Flow-Cytometry-NBP2-67180-img0001.jpg)
![Western Blot: TAK1 Antibody (JM73-19) [NBP2-67180] - Analysis of TAK1 on human placenta tissue lysate using anti-TAK1 antibody at 1/1,000 dilution.](http://images.novusbio.com/fullsize/TAK1-Antibody-JM73-19-Western-Blot-NBP2-67180-img0006.jpg)
![Immunocytochemistry/Immunofluorescence: TAK1 Antibody (JM73-19) [NBP2-67180] - Staining TAK1 in A431 cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/TAK1-Antibody-JM73-19-Immunocytochemistry-Immunofluorescence-NBP2-67180-img0002.jpg)
![Immunohistochemistry-Paraffin: TAK1 Antibody (JM73-19) [NBP2-67180] - Analysis of paraffin-embedded human placenta tissue using anti-TAK1 antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/TAK1-Antibody-JM73-19-Immunohistochemistry-Paraffin-NBP2-67180-img0003.jpg)
![Immunohistochemistry-Paraffin: TAK1 Antibody (JM73-19) [NBP2-67180] - Analysis of paraffin-embedded human prostate tissue using anti-TAK1 antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/TAK1-Antibody-JM73-19-Immunohistochemistry-Paraffin-NBP2-67180-img0004.jpg)
![Immunohistochemistry-Paraffin: CXCL8/IL-8 Antibody [NBP2-16958] - Human gastric cancer. CXCL8 / IL8 stained by CXCL8 / IL8 antibody diluted at 1:500.Antigen Retrieval: Citrate buffer, pH 6.0, 15 min.](http://images.novusbio.com/fullsize/CXCL8-IL-8-Antibody-Immunohistochemistry-Paraffin-NBP2-16958-img0009.jpg "Immunohistochemistry-Paraffin: CXCL8/IL-8 Antibody [NBP2-16958] - Human gastric cancer. CXCL8 / IL8 stained by CXCL8 / IL8 antibody diluted at 1:500.Antigen Retrieval: Citrate buffer, pH 6.0, 15 min.")
![Western Blot: CXCL8/IL-8 Antibody [NBP2-16958] - Non-transfected (-) and transfected (+) 293T whole cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with CXCL8/IL-8 antibody (NBP2-16958) diluted at 1:5000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp2-16958_rabbit-polyclonal-cxcl8-il-8-antibody-91020242014685.jpg)
![Western Blot: CXCL8/IL-8 Antibody [NBP2-16958] - HepG2 whole cell extract and conditioned medium (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with CXCL8/IL-8 antibody (NBP2-16958) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp2-16958_rabbit-polyclonal-cxcl8-il-8-antibody-91020242041287.jpg)
![Western Blot: CXCL8/IL-8 Antibody [NBP2-16958] - Human leukocyte (30 ug) was separated by 15% SDS-PAGE, and the membrane was blotted with CXCL8/IL-8 antibody (NBP2-16958) diluted at 1:500. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp2-16958_rabbit-polyclonal-cxcl8-il-8-antibody-9102024206337.jpg)
![Western Blot: RelA/NFkB p65 Antibody [NB100-56502] - Analysis of extracts from various cell lines using NFkB p65 antibody at 1:100 (5 ug/mL).](http://images.novusbio.com/fullsize/RelA-NFkB-p65-Antibody-Western-Blot-NB100-56502-img0006.jpg "Western Blot: RelA/NFkB p65 Antibody [NB100-56502] - Analysis of extracts from various cell lines using NFkB p65 antibody at 1:100 (5 ug/mL).")
![Immunocytochemistry/Immunofluorescence: RelA/NFkB p65 Antibody [NB100-56502] - p65 antibody was tested in HeLa cells with DyLight 488 (green). Nuclei and alpha-tubulin were counterstained with DAPI (blue) and Dylight 550 (red).](http://images.novusbio.com/fullsize/RelA-NFkB-p65-Antibody-Immunocytochemistry-Immunofluorescence-NB100-56502-img0004.jpg)
![Western Blot: RelA/NFkB p65 Antibody [NB100-56502] - Analysis of p65 in HeLa cell lysate in the 1) absence and 2) presence of immunizing peptide using this antibody.](http://images.novusbio.com/fullsize/RelA-NFkB-p65-Antibody-Western-Blot-NB100-56502-img0005.jpg)
![Western Blot: IFIT2 Antibody [NBP1-31164] - p115 and Sec16A are required for optimal IRF-3 activation in response to activation of cytosolic RNA and DNA sensors.HeLa cells were infected with lentiviral vectors encoding shRNA targeting p115. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.ppat.1002747) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/IFIT2-Antibody-Western-Blot-NBP1-31164-img0006.jpg "Western Blot: IFIT2 Antibody [NBP1-31164] - p115 and Sec16A are required for optimal IRF-3 activation in response to activation of cytosolic RNA and DNA sensors.HeLa cells were infected with lentiviral vectors encoding shRNA targeting p115. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.ppat.1002747) licensed under a CC-BY license.")
![Western Blot: IFIT2 Antibody [NBP1-31164] - Sample(30 ug of whole cell lysate)A:A431 B:Hep G2 7.5% SDS PAGE, antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/IFIT2-Antibody-Western-Blot-NBP1-31164-img0003.jpg)
![Western Blot: IFIT2 Antibody [NBP1-31164] - p115 & Sec16A are required for optimal IRF-3 activation in response to activation of cytosolic RNA & DNA sensors.HeLa cells were infected with lentiviral vectors encoding shRNA targeting p115 (A) or Sec16A (B) & non-targeting (NT) control shRNA for 24 h followed by puromycin selection (1.5 µg/ml) for 5 days. Cells were left untreated or stimulated with poly I:C (1 µg/ml), poly dA:dT (1 µg/ml) or SeV (200 HAU/ml) for 16 h. Whole-cell lysates were prepared & subjected to immunoblot analysis with indicated antibodies. One of two independent experiments with similar results is shown. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/22792062), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-31164_rabbit-polyclonal-ifit2-antibody-310202415171321.jpg)
![IFIT2 antibody [N1], N-term detects IFIT2 protein at endoplasmic reticulum by immunofluorescent analysis.Sample: HeLa cells were fixed in 4% paraformaldehyde at RT for 15 min.Green: IFIT2 protein stained by IFIT2 antibody [N1], N-term (NBP1-31164) diluted at 1:200.Red: alpha Tubulin, a cytoskeleton marker, stained by alpha Tubulin antibody [B-5-1-2] diluted at 1:10000.Blue: Hoechst 33342 staining.](http://images.novusbio.com/fullsize/nbp1-31164_rabbit-polyclonal-ifit2-antibody-immunocytochemistry-immunofluorescence-1411202518351210.jpg)
![Western Blot: TLR2 Antibody [NB100-56573] - Analysis of TLR2 in (A) 15 ugs of Raw cell lysate (B) Mouse TLR2 transfected cell lysate and (C) Ramos cell lysate. 1 ug/ml.](http://images.novusbio.com/fullsize/TLR2-Antibody-Western-Blot-NB100-56573-img0001.jpg "Western Blot: TLR2 Antibody [NB100-56573] - Analysis of TLR2 in (A) 15 ugs of Raw cell lysate (B) Mouse TLR2 transfected cell lysate and (C) Ramos cell lysate. 1 ug/ml.")
![Western Blot: Coronin-1a Antibody (4G10) [H00011151-M01] - CORO1A monoclonal antibody (M01), clone 4G10 Analysis of CORO1A expression in K-562.](http://images.novusbio.com/fullsize/Coronin-1a-Antibody-4G10-Western-Blot-H00011151-M01-img0007.jpg "Western Blot: Coronin-1a Antibody (4G10) [H00011151-M01] - CORO1A monoclonal antibody (M01), clone 4G10 Analysis of CORO1A expression in K-562.")
![Immunohistochemistry-Paraffin: Coronin-1a Antibody (4G10) [H00011151-M01] - Analysis of monoclonal antibody to CORO1A on formalin-fixed paraffin-embedded human lung. Antibody concentration 3 ug/ml.](http://images.novusbio.com/fullsize/Coronin-1a-Antibody-4G10-Immunohistochemistry-Paraffin-H00011151-M01-img0005.jpg)
![Sandwich ELISA: Coronin-1a Antibody (4G10) [H00011151-M01] - Detection limit for recombinant GST tagged CORO1A is approximately 0.1ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/Coronin-1a-Antibody-4G10-Sandwich-ELISA-H00011151-M01-img0006.jpg)
![Western Blot: Fc gamma RIIA/CD32a Antibody (9G5) [NBP1-47735] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A.](http://images.novusbio.com/fullsize/Fc-gamma-RIIA-CD32a-Antibody-9G5-Western-Blot-NBP1-47735-img0022.jpg "Western Blot: Fc gamma RIIA/CD32a Antibody (9G5) [NBP1-47735] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A.")
![Immunocytochemistry/Immunofluorescence: Fc gamma RIIA/CD32a Antibody (9G5) [NBP1-47735] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY FCGR2A.](http://images.novusbio.com/fullsize/Fc-gamma-RIIA-CD32a-Antibody-9G5-Immunocytochemistry-Immunofluorescence-NBP1-47735-img0013.jpg)
![Immunohistochemistry-Paraffin: Fc gamma RIIA/CD32a Antibody (9G5) [NBP1-47735] - Staining of paraffin-embedded Human prostate tissue using anti-FCGR2A mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Fc-gamma-RIIA-CD32a-Antibody-9G5-Immunohistochemistry-Paraffin-NBP1-47735-img0021.jpg)
![Immunohistochemistry-Paraffin: Fc gamma RIIA/CD32a Antibody (9G5) [NBP1-47735] - Staining of paraffin-embedded Adenocarcinoma of Human colon tissue using anti-FCGR2A mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Fc-gamma-RIIA-CD32a-Antibody-9G5-Immunohistochemistry-Paraffin-NBP1-47735-img0014.jpg)
![Immunohistochemistry-Paraffin: Fc gamma RIIA/CD32a Antibody (9G5) [NBP1-47735] - Staining of paraffin-embedded Human breast tissue using anti-FCGR2A mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Fc-gamma-RIIA-CD32a-Antibody-9G5-Immunohistochemistry-Paraffin-NBP1-47735-img0015.jpg)
![Immunohistochemistry-Paraffin: Fc gamma RIIA/CD32a Antibody (9G5) [NBP1-47735] - Staining of paraffin-embedded Human colon tissue using anti-FCGR2A mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Fc-gamma-RIIA-CD32a-Antibody-9G5-Immunohistochemistry-Paraffin-NBP1-47735-img0016.jpg)
![Immunohistochemistry-Paraffin: Fc gamma RIIA/CD32a Antibody (9G5) [NBP1-47735] - Staining of paraffin-embedded Human endometrium tissue using anti-FCGR2A mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Fc-gamma-RIIA-CD32a-Antibody-9G5-Immunohistochemistry-Paraffin-NBP1-47735-img0017.jpg)
![Immunohistochemistry-Paraffin: Fc gamma RIIA/CD32a Antibody (9G5) [NBP1-47735] - Staining of paraffin-embedded Human Kidney tissue using anti-FCGR2A mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Fc-gamma-RIIA-CD32a-Antibody-9G5-Immunohistochemistry-Paraffin-NBP1-47735-img0018.jpg)
![Immunohistochemistry-Paraffin: Fc gamma RIIA/CD32a Antibody (9G5) [NBP1-47735] - Staining of paraffin-embedded Human lung tissue using anti-FCGR2A mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Fc-gamma-RIIA-CD32a-Antibody-9G5-Immunohistochemistry-Paraffin-NBP1-47735-img0019.jpg)
![Immunohistochemistry-Paraffin: Fc gamma RIIA/CD32a Antibody (9G5) [NBP1-47735] - Staining of paraffin-embedded Human pancreas tissue using anti-FCGR2A mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Fc-gamma-RIIA-CD32a-Antibody-9G5-Immunohistochemistry-Paraffin-NBP1-47735-img0020.jpg)
![Immunoprecipitation: Fc gamma RIIA/CD32a Antibody (9G5) [NBP1-47735] - Lane 1: Negative Control Lane 2: NBP1-47738 Lane 3: NBP1-47739 Lane 4: NBP1-47740 Lane 5: NBP1-47741 Lane 6: NBP1-47742 Lane 7: NBP1-47734 Lane 8: NBP1-47735 Lane 9: NBP1-47736 Lane 10: NBP1-47737 Lane 11: NBP1-47743 Lane 12: NBP1-47744](http://images.novusbio.com/fullsize/Fc-gamma-RIIA-CD32a-Antibody-9G5-Immunoprecipitation-NBP1-47735-img0023.jpg)